263 related articles for article (PubMed ID: 23970101)
1. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival.
Lu G; Shan T; He S; Ren M; Zhu M; Hu Y; Lu X; Zhang D
Oncol Rep; 2013 Nov; 30(5):2238-44. PubMed ID: 23970101
[TBL] [Abstract][Full Text] [Related]
2. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
3. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
4. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.
Liu L; Li Y; Zhang S; Yu D; Zhu M
Oncol Rep; 2012 Jan; 27(1):168-73. PubMed ID: 21956590
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of CENP-E contributes to the development of hepatocellular carcinoma and is associated with adverse clinical features.
He P; Hu P; Yang C; He X; Shao M; Lin Y
Biomed Pharmacother; 2020 Mar; 123():109795. PubMed ID: 31881483
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma.
Zhang CZ; Cao Y; Yun JP; Chen GG; Lai PB
Histopathology; 2012 Jun; 60(7):1114-24. PubMed ID: 22372401
[TBL] [Abstract][Full Text] [Related]
9. [Expression of centromere protein A in hepatocellular carcinoma].
Li YM; Liu XH; Cao XZ; Wang L; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):175-8. PubMed ID: 17535684
[TBL] [Abstract][Full Text] [Related]
10. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of centromere protein A in human lung adenocarcinoma.
Wu Q; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH
Lung Cancer; 2012 Aug; 77(2):407-14. PubMed ID: 22542705
[TBL] [Abstract][Full Text] [Related]
12. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
13. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.
Li Y; Zhu Z; Zhang S; Yu D; Yu H; Liu L; Cao X; Wang L; Gao H; Zhu M
PLoS One; 2011 Mar; 6(3):e17794. PubMed ID: 21423629
[TBL] [Abstract][Full Text] [Related]
14. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
16. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
[TBL] [Abstract][Full Text] [Related]
19. CENP-H regulates the cell growth of human hepatocellular carcinoma cells through the mitochondrial apoptotic pathway.
Lu G; Hou H; Lu X; Ke X; Wang X; Zhang D; Zhao Y; Zhang J; Ren M; He S
Oncol Rep; 2017 Jun; 37(6):3484-3492. PubMed ID: 28498417
[TBL] [Abstract][Full Text] [Related]
20. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
Kanda M; Sugimoto H; Nomoto S; Oya H; Hibino S; Shimizu D; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Oncol; 2015 Feb; 46(2):641-8. PubMed ID: 25405901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]